Changes in pre- and postoperative serum leptin concentrations in dogs with gallbladder mucocele and cholelithiasis

Abstract

BackgroundLeptin has been shown to have various physiological and pathological roles in the canine gallbladder. In this study, we performed pre- and postoperative short-term follow-up analyses to confirm changes in serum leptin levels before and after cholecystectomy due to gallbladder mucocele (GBM) or cholelithiasis in dogs.ResultsTwenty-six cholecystectomized dogs (GBM: n\u2009=\u200914; cholelithiasis: n\u2009=\u200912) for prophylactic or clinical symptom relief were enrolled in the present study. Dogs were subgrouped according to clinical symptoms and prognosis after surgery as follows: 1) asymptomatic group (n\u2009=\u200913), 2) recovery group (n\u2009=\u20098), and 3) death group (n\u2009=\u20095). Liver enzymes, total bilirubin, lipid profiles, and leptin concentrations were determined from sera on the pre-operative day and at 1, 3, and 7\u2009days postoperation. Serum leptin concentrations were gradually but significantly decreased in the asymptomatic group (p\u2009=\u20090.008, 0.004, and 0.004 on days 1, 3, and 7, respectively, compared with that before surgery) and the recovery group (p\u2009=\u20090.048 and 0.048 on days 3 and 7, respectively, compared with that before surgery). However, in the death group, leptin concentrations did not differ significantly over time (p\u2009=\u20090.564). Additionally, serum leptin levels in the recovery group (p\u2009=\u20090.006) and death group (p\u2009=\u20090.021) were significantly higher than those in the asymptomatic group. Liver enzymes and total bilirubin (T-Bil) were significantly decreased only in the recovery group, particularly on day 7. In the asymptomatic group, liver enzymes and T-Bil were not changed significantly over time, and in the death group, only T-Bil was significantly decreased on day 7. Total cholesterol and triglyceride levels were not significantly decreased over time in all groups.ConclusionsThese results indicate that leptin is a potential biomarker reflecting the severity and prognosis of GBM and cholelithiasis both before and after cholecystectomy in dogs.